Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Manuscript
  • Published:

Myeloma

Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-γ (MIG) gene expression in B-cell malignancy

Leukemia volume 19, pages 1471–1478 (2005)Cite this article

Abstract

MUM1 (multiple myeloma oncogene 1)/IRF4 (interferon regulatory factor 4) is a transcription factor that is activated as a result of t(6;14)(p25;q32) in multiple myeloma. MUM1 expression is seen in various B-cell lymphomas and predicts an unfavorable outcome in some lymphoma subtypes. To elucidate its role in B-cell malignancies, we prepared MUM1-expressing Ba/F3 cells, which proliferated until higher cellular density than the parental cells, and performed cDNA microarray analysis to identify genes whose expression is regulated by MUM1. We found that the expression of four genes including FK506-binding protein 3 (FKBP3), the monokine induced by interferon-γ(MIG), Fas apoptotic inhibitory molecule (Faim) and Zinc-finger protein 94 was altered in the MUM1-expressing cells. We then focused on MIG since its expression was immediately upregulated by MUM1. In reporter assays, MUM1 activated the MIG promoter in cooperation with PU.1, and the interaction between MUM1 and the MIG promoter sequence was confirmed. The expression of MIG was correlated with that of MUM1 in B-CLL cell lines, and treatment with neutralizing antibodies against MIG and its receptor, CXCR3, slightly inhibited the proliferation of two MUM1-expressing lines. These results suggest that MUM1 plays roles in the progression of B-cell lymphoma/leukemia by regulating the expression of various genes including MIG.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

Accession codes

Accessions

GenBank/EMBL/DDBJ

References

  1. Iida S, Rao PH, Butler M, Corradini P, Boccadoro M, Klein B et al. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma. Nat Genet 1997; 17: 226–230.

    Article  CAS  Google Scholar 

  2. Tajima E, Uranishi M, Iida S, Komatsu H, Nitta M, Ueda R . Global real-time quantification/reverse transcription-polymerase chain reaction for detecting proto-oncogenes associated with 14q32 chromosomal translocation in multiple myeloma. Haematologica 2005; 90: 559–562.

    CAS  PubMed  Google Scholar 

  3. Matsuyama T, Grossman A, Mittrucker HW, Siderovski DP, Kiefer F, Kawakami T et al. Molecular cloning of LSIRF, a lymphoid-specific member of the interferon regulatory factor family that binds the interferon-stimulated response element (ISRE). Nucleic Acids Res 1995; 23: 2127–2136.

    Article  CAS  Google Scholar 

  4. Yamagata T, Nishida J, Tanaka S, Sakai R, Mitani K, Yoshida M et al. A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes. Mol Cell Biol 1996; 16: 1283–1294.

    Article  CAS  Google Scholar 

  5. Eisenbeis CF, Singh H, Storb U . Pip, a novel IRF family member, is a lymphoid-specific, PU.1-dependent transcriptional activator. Genes Dev 1995; 9: 1377–1387.

    Article  CAS  Google Scholar 

  6. Mittrucker HW, Matsuyama T, Grossman A, Kundig TM, Potter J, Shahinian A et al. Requirement for the transcription factor LSIRF/IRF4 for mature B and T lymphocyte function. Science 1997; 275: 540–543.

    Article  CAS  Google Scholar 

  7. Pongubala JM, Atchison ML . PU.1 can participate in an active enhancer complex without its transcriptional activation domain. Proc Natl Acad Sci USA 1997; 94: 127–132.

    Article  CAS  Google Scholar 

  8. Pernis AB . The role of IRF-4 in B and T cell activation and differentiation. J Interferon Cytokine Res 2002; 22: 111–120.

    Article  CAS  Google Scholar 

  9. Pongubala JM, Nagulapalli S, Klemsz MJ, McKercher SR, Maki RA . Atchison ML. PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity. Mol Cell Biol 1992; 12: 368–378.

    Article  CAS  Google Scholar 

  10. Eisenbeis CF, Singh H, Storb U . PU.1 is a component of a multiprotein complex which binds an essential site in the murine immunoglobulin lambda 2–4 enhancer. Mol Cell Biol 1993; 13: 6452–6461.

    Article  CAS  Google Scholar 

  11. Himmelmann A, Riva A, Wilson GL, Lucas BP, Thevenin C, Kehrl JH . PU.1/Pip and basic helix loop helix zipper transcription factors interact with binding sites in the CD20 promoter to help confer lineage- and stage-specific expression of CD20 in B lymphocytes. Blood 1997; 90: 3984–3995.

    CAS  PubMed  Google Scholar 

  12. Tsuboi K, Iida S, Inagaki H, Kato M, Hayami Y, Hanamura I et al. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies. Leukemia 2000; 14: 449–456.

    Article  CAS  Google Scholar 

  13. Imaizumi Y, Kohno T, Yamada Y, Ikeda S, Tanaka Y, Tomonaga M et al. Possible involvement of interferon regulatory factor 4 (IRF4) in a clinical subtype of adult T-cell leukemia. Jpn J Cancer Res 2001; 92: 1284–1292.

    Article  CAS  Google Scholar 

  14. Alizadeh AA, Eisen MB, Davis RE, Ma C, Lossos IS, Rosenwald A et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000; 403: 503–511.

    Article  CAS  Google Scholar 

  15. Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood 2004; 103: 275–282.

    Article  CAS  Google Scholar 

  16. Ito M, Iida S, Inagaki H, Tsuboi K, Komatsu H, Yamaguchi M et al. MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL). Jpn J Cancer Res 2002; 93: 685–694.

    Article  CAS  Google Scholar 

  17. Chang CC, Lorek J, Sabath DE, Li Y, Chitambar CR, Logan B et al. Expression of MUM1/IRF4 correlates with clinical outcome in patients with B-cell chronic lymphocytic leukemia. Blood 2002; 100: 4671–4675.

    Article  CAS  Google Scholar 

  18. Ding J, Komatsu H, Wakita A, Kato-Uranishi M, Ito M, Satoh A et al. Familial essential thrombocythemia associated with a dominant-positive activating mutation of the c-MPL gene, which encodes for the receptor for thrombopoietin. Blood 2004; 103: 4198–4200.

    Article  CAS  Google Scholar 

  19. Ohmori Y, Schreiber RD, Hamilton TA . Synergy between interferon-gamma and tumor necrosis factor-alpha in transcriptional activation is mediated by cooperation between signal transducer and activator of transcription 1 and nuclear factor kappaB. J Biol Chem 1997; 272: 14899–14907.

    Article  CAS  Google Scholar 

  20. Oikawa T, Yamada T . Molecular biology of the Ets family of transcription factors. Gene 2003; 303: 11–34.

    Article  CAS  Google Scholar 

  21. Frank SR, Schroeder M, Fernandez P, Taubert S, Amati B . Binding of c-Myc to chromatin mediates mitogen-induced acetylation of histone H4 and gene activation. Genes Dev 2001; 15: 2069–2082.

    Article  CAS  Google Scholar 

  22. Ishida T, Utsunomiya A, Iida S, Inagaki H, Takatsuka Y, Kusumoto S et al. Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003; 9: 3625–3634.

    CAS  PubMed  Google Scholar 

  23. Kraft M, Riedel S, Maaser C, Kucharzik T, Steinbuechel A, Domschke W et al. IFN-gamma synergizes with TNF-alpha but not with viable. H pylori in up-regulating CXC chemokine secretion in gastric epithelial cells. Clin Exp Immunol 2001; 126: 474–481.

    Article  CAS  Google Scholar 

  24. Hiroi M, Ohmori Y . The transcriptional coactivator CREB-binding protein cooperates with STAT1 and NF-kappa B for synergistic transcriptional activation of the CXC ligand 9/monokine induced by interferon-gamma gene. J Biol Chem 2003; 278: 651–660.

    Article  CAS  Google Scholar 

  25. Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark-Lewis I et al. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokines IP10 and Mig. Eur J Immunol 1998; 28: 961–972.

    Article  CAS  Google Scholar 

  26. Hrdlickova R, Nehyba J, Bose Jr HR . Interferon regulatory factor 4 contributes to transformation of v-Rel-expressing fibroblasts. Mol Cell Biol 2001; 21: 6369–6386.

    Article  CAS  Google Scholar 

  27. Jin YJ, Burakoff SJ, Bierer BE . Molecular cloning of a 25-kDa high affinity rapamycin binding protein, FKBP25. J Biol Chem 1992; 267: 10942–10945.

    CAS  PubMed  Google Scholar 

  28. Mamane Y, Sharma S, Petropoulos L, Lin R, Hiscott J . Posttranslational regulation of IRF-4 activity by the immunophilin FKBP52. Immunity 2000; 12: 129–140.

    Article  CAS  Google Scholar 

  29. Farber JM . Mig and IP-10: CXC chemokines that target lymphocytes. J Leukoc Biol 1997; 61: 246–257.

    Article  CAS  Google Scholar 

  30. Farber JM . A macrophage mRNA selectively induced by gamma-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA. 1990; 87: 5238–5242.

    Article  CAS  Google Scholar 

  31. Qin S, Rottman JB, Myers P, Kassam N, Weinblatt M, Loetscher M et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998; 101: 746–754.

    Article  CAS  Google Scholar 

  32. Weng Y, Siciliano SJ, Waldburger KE, Sirotina-Meisher A, Staruch MJ, Daugherty BL et al. Binding and functional properties of recombinant and endogenous CXCR3 chemokine receptors. J Biol Chem 1998; 273: 18288–18291.

    Article  CAS  Google Scholar 

  33. Jones D, Benjamin RJ, Shahsafaei A, Dorfman DM . The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia. Blood 2000; 95: 627–632.

    CAS  PubMed  Google Scholar 

  34. Trentin L, Agostini C, Facco M, Piazza F, Perin A, Siviero M et al. The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. J Clin Invest 1999; 104: 115–121.

    Article  CAS  Google Scholar 

  35. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I et al. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996; 184: 963–969.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank Ms C Fukuyama and Ms C Nakagawa for their skillful technical assistance. This work was supported in part by Grant-in-Aids for SI and RU from the Ministry of Education, Science, Sports and Culture and for SI and RU from the Ministry of Health, Labor and Welfare. SI is supported by a Grant of the Princess Takamatsu Cancer Research Fund.

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

    M Uranishi, S Iida, T Sanda, T Ishida, E Tajima, H Komatsu & R Ueda

  2. Department of Internal Medicine, Division of Hematology, Aichi Medical University, Aichi-gun, Japan

    E Tajima & M Ito

  3. Department of Clinical Pathology, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan

    H Inagaki

Authors
  1. M Uranishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. S Iida
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. T Sanda
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. T Ishida
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. E Tajima
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. M Ito
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Komatsu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. H Inagaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. R Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to S Iida.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uranishi, M., Iida, S., Sanda, T. et al. Multiple myeloma oncogene 1 (MUM1)/interferon regulatory factor 4 (IRF4) upregulates monokine induced by interferon-γ (MIG) gene expression in B-cell malignancy. Leukemia 19, 1471–1478 (2005). https://doi.org/10.1038/sj.leu.2403833

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.leu.2403833

Keywords

This article is cited by

Search

Advanced search

Quick links